Patent ID: 8673934
Filing Date: 2014-03-18
Classification: A61K,A61P,C12N

Abstract:
1. A method for treating the development of a bacterial infection after acute stroke in order to reduce lethality and morbidity from pneumonia, urinary tract infection, and/or sepsis, wherein said method comprises administering, to a patient who has had a stroke, at least one anti-infective agent comprising at least one antibiotic in a pharmaceutical preparation, wherein said antibiotic is selected from the group consisting of moxifloxacin (1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]-pyridin-6-yl]-4-oxoquinoline-3-carboxylic acid), mezlocillin, sulbactam and combinations thereof; and optionally at least one immunomodulating agent, and starting the anti-infective therapy within 72 hours following the stroke.